UK markets closed

ESSA Pharma Inc. (EPIX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.75+0.10 (+1.50%)
At close: 04:00PM EDT
6.45 -0.30 (-4.44%)
After hours: 06:16PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Cash flows from operating activities
Net income
-27,734
-26,582
-35,103
-36,805
-23,445
-
Depreciation & amortisation
102.809
118.491
121.787
109.464
110.324
-
Deferred income taxes
-
-
-
0
-280
0
Stock-based compensation
3,943
5,007
7,888
9,476
7,523
-
Change in working capital
1,660
2,339
-780.008
1,947
-1,239
-
Accounts payable
-
-
-
2,668
-46.358
-1,014
Other working capital
-22,999
-19,782
-27,999
-25,416
-16,983
-
Other non-cash items
18.889
7.316
-175.908
-66.486
224.071
-
Net cash provided by operating activities
-22,999
-19,782
-27,999
-25,416
-16,983
-
Cash flows from investing activities
Acquisitions, net
-
-
-
-
-
-246.906
Purchases of investments
-209,184
-365,204
-296,012
-57,026
-22,011
-
Sales/maturities of investments
278,770
361,677
242,959
22,000
0
-
Other investing activities
-
-
-
-
274.085
201.399
Net cash used for investing activities
69,586
-3,527
-53,053
-35,015
-21,737
-
Cash flows from financing activities
Debt repayment
-67.588
-136.866
-134.023
-100.282
-4,007
-
Common stock issued
-
-
0
150,000
48,990
36,000
Dividends paid
-
-
-
0
0
0
Other financing activities
-
-
-
-9,229
-3,513
17,775
Net cash used provided by (used for) financing activities
791.092
-68.157
252.735
141,991
41,777
-
Net change in cash
47,382
-23,375
-80,749
81,504
2,998
-
Cash at beginning of period
44,301
57,076
137,825
56,321
53,323
-
Cash at end of period
91,678
33,702
57,076
137,825
56,321
-
Free cash flow
Operating cash flow
-22,999
-19,782
-27,999
-25,416
-16,983
-
Free cash flow
-22,999
-19,782
-27,999
-25,416
-16,983
-